Cargando…
Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446136/ https://www.ncbi.nlm.nih.gov/pubmed/30968060 http://dx.doi.org/10.1093/ofid/ofz142 |
_version_ | 1783408306476285952 |
---|---|
author | Abdullahi, Adam Fopoussi, Olga Mafotsing Torimiro, Judith Atkins, Mark Kouanfack, Charles Geretti, Anna Maria |
author_facet | Abdullahi, Adam Fopoussi, Olga Mafotsing Torimiro, Judith Atkins, Mark Kouanfack, Charles Geretti, Anna Maria |
author_sort | Abdullahi, Adam |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6446136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64461362019-04-09 Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting Abdullahi, Adam Fopoussi, Olga Mafotsing Torimiro, Judith Atkins, Mark Kouanfack, Charles Geretti, Anna Maria Open Forum Infect Dis Corrigendum Oxford University Press 2019-04-03 /pmc/articles/PMC6446136/ /pubmed/30968060 http://dx.doi.org/10.1093/ofid/ofz142 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Corrigendum Abdullahi, Adam Fopoussi, Olga Mafotsing Torimiro, Judith Atkins, Mark Kouanfack, Charles Geretti, Anna Maria Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting |
title | Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting |
title_full | Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting |
title_fullStr | Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting |
title_full_unstemmed | Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting |
title_short | Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting |
title_sort | corrigendum: hepatitis b virus (hbv) infection and re-activation during nucleos(t)ide reverse transcriptase inhibitor–sparing antiretroviral therapy in a high–hbv endemicity setting |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446136/ https://www.ncbi.nlm.nih.gov/pubmed/30968060 http://dx.doi.org/10.1093/ofid/ofz142 |
work_keys_str_mv | AT abdullahiadam corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting AT fopoussiolgamafotsing corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting AT torimirojudith corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting AT atkinsmark corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting AT kouanfackcharles corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting AT gerettiannamaria corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting |